Neurological Disease Current Events | Neurological Disease News | 9
|
| Page
9 of
17 |
335 Results |
|
|
|
Sort By:
Page Views | Date |
Interactive 3-D Map in OR Can Better Guide Jefferson Neurological Surgeons Through the Brain During Procedure
Jefferson Hospital for Neuroscience is one of first medical centers in the U.S. to develop and begin using translational, interactive 3-D technology to map the human brain and help guide neurological surgeons during epilepsy surgery and procedures to remove malignant brain tumors. view more (2007-07-31)
Dr A.H. Heineken Prize for Medicine 2002 (USD 150,000) for Dennis J. Selkoe
The Royal Netherlands Academy of Arts and Sciences has awarded the Dr A.H. Heineken Prize for Medicine 2002 (USD 150,000) to Professor Dennis J. Selkoe, M.D. Harvard Medical School, Boston, MA, United States ‘for his invaluable contribution to the development of the molecular study of diseases of the brain, in particular Alzheimer’s... view more... (2002-04-15)
Mount Sinai launches combination therapy trial to treat Relapsing-Remitting Multiple Sclerosis
Mount Sinai School of Medicine is the Clinical Coordinating Center for the first study to assess the effectiveness of combining two FDA approved medications as initial treatment for people with Relapsing Remitting Multiple Sclerosis view more (2006-04-12)
HIV dementia alarmingly high in Africa
An international study led by Johns Hopkins suggests that the rate of HIV-associated dementia is so high in sub-Saharan Africa that HIV dementia along with Alzheimer's disease and dementia from strokes may be among the most common forms of dementia in the world. view more (2007-01-30)
Mediterranean diet associated with reduced risk of Alzheimer's disease
Eating a Mediterranean diet, which emphasizes fruits, vegetables and olive oil and includes little red meat, is associated with a lower risk for Alzheimer's disease. view more (2006-10-10)
New synthetic compounds appear to prevent brain cell death
Spanish chemists have developed a promising set of synthetic compounds that one day could help slow or perhaps halt the progression of Alzheimer's disease and other neurological disorders. view more (2005-12-21)
Barrow researchers identify new brain receptor, possible target for Alzheimer's treatment
Barrow Neurological Institute researchers have identified a novel receptor in the brain that is extremely sensitive to beta-amyloid peptide (AB) and may play a key role in early stages of Alzheimer's disease. view more (2009-07-17)
MS patients not receiving medications to slow disease progression, research shows
Neurologists at Wake Forest University Baptist Medical Center have found that many patients diagnosed with multiple sclerosis (MS) are not taking or being prescribed drugs approved to treat the disease. view more (2007-04-17)
Study examines testing model to predict and diagnose new cases of dementia
A report published by researchers at Albert Einstein College of Medicine of Yeshiva University in the August 20 issue of JAMA suggests that measuring how much an individual's performance varies across several neuropsychological tests enhances the accuracy of predicting whether older adults will develop dementia. view more (2008-08-20)
Cell study explains why younger people more at risk of vCJD
Specific cells within the immune system could help explain why younger people are more susceptible to variant CJD, scientists believe. view more (2009-10-14)
Clues to visual variant Alzheimer's; myopia and diabetic retinopathy risk
Two studies are of particular note in today's Scientific Program of the 2009 Joint Meeting of the American Academy of Ophthalmology (AAO) and the Pan-American Association of Ophthalmology (PAAO): a report by Swiss neuro-ophthalmic researchers about vision exam clues that should make ophthalmologists suspect an atypical variant of Alzheimer's... view more... (2009-10-26)
IVF does not increase risk of developmental disorders in children
Couples who need IVF in order to become pregnant can be reassured that this will not lead to developmental problems in early infancy. view more (2008-07-08)
The endocannabinoids: Functional roles and therapeutic opportunities
Cannabis (marijuana) is the most widely produced plant-based illicit drug worldwide and the illegal drug most frequently used in Europe. Its use increased in almost all EU countries during the 1990s, in particular among young people, including school students. view more (2007-10-15)
Scientists Shed Light on Long-Distance Signaling in Developing Neurons
A longstanding puzzle in neurodevelopment may have yielded up a key secret. A team led by scientists at Weill Cornell Medical College says they have determined how events at the very tips of the developing neuron's long, skinny axon affect gene transcription back in the cell's distant nucleus. view more (2008-02-20)
arrow researcher finds natural hydrogel helps heal spinal cord
Research led by a scientist at the Barrow Neurological Institute at St. Joseph's Hospital and Medical Center has shown injecting biomaterial gel into a spinal cord injury site provides significantly improved healing. view more (2009-09-17)
Simple eye scan opens window to multiple sclerosis
A five-minute eye exam might prove to be an inexpensive and effective way to gauge and track the debilitating neurological disease multiple sclerosis, potentially complementing costly magnetic resonance imaging to detect brain shrinkage - a characteristic of the disease's progression. view more (2007-10-16)
Cognitive problems associated with diabetes duration and severity
Individuals with mild cognitive impairment appear more likely to have earlier onset, longer duration and greater severity of diabetes, according to a report in the August issue of Archives of Neurology, one of the JAMA/Archives journals. view more (2008-08-12)
Disease-modifying therapy in multiple sclerosis
Major pan-European survey shows treatment is still delayed A major pan-European survey[1,2] of over 300 neurologists in seven EC countries (France, Germany, Italy, the Netherlands, Spain, Sweden and the UK) has revealed that, on average, disease-modifying beta interferon treatment for multiple sclerosis (MS) is not initiated until a patient has... view more... (2002-08-21)
Separating the brain's 'bad' from 'good' iron
Duke University chemists are developing ways to bind up iron in the brain to combat the neurological devastation of Parkinson's and Alzheimer's diseases. view more (2007-08-24)
Dual treatment for stroke leads to improved recovery rates, reduced mortality
It appears that stroke patients who receive both intravenous thrombolysis - a minimally invasive treatment that dissolves abnormal blood clots - and endovascular interventions - such as drugs and implanting medical devices - are much more likely to recover and have lower chances of dying. view more (2008-11-13)
|
|
| Page
9 of
17 |
335 Results |
|
|
|
Sort By:
Page Views | Date |
|
